Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review
Open Access
- 1 April 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 20 (4) , 799-808
Abstract
: Poloxamer 188 (P188) is an FDA-approved biocompatible block copolymer composed of repeating units of Poly(Ethylene Oxide) (PEO) and poly(propylene oxide) (PPO). Due to its amphiphilic nature and high Hydrophile-Lipophile Balance (HLB) value of 29, P188 is used as a stabilizer/emulsifier in many cosmetics and pharmaceutical preparations. While the applications of P188 as an excipient are widely explored, the data on the pharmacological activity of P188 are scarce. Notably, the neuroprotective potential of P188 has gained a lot of interest. Therefore, this systematic review is aimed at summarizing evidence of neuroprotective potential of P188 in CNS disorders. The PRISMA model was used, and five databases (Google Scholar, Scopus, Wiley Online Library, ScienceDirect, and PubMed) were searched with relevant keywords. The search resulted in 11 articles, which met the inclusion criteria. These articles described the protective effects of P188 on traumatic brain injury or mechanical injury in cells, neurotoxicity, Parkinson’s disease, Amyotrophic lateral sclerosis (ALS), and ischemia/ reperfusion injury from stroke. All the articles were original research in experimental or pre-clinical stages using animal models or in vitro systems. The reported activities demonstrated the potential of P188 as a neuroprotective agent in improving CNS conditions such as neurodegeneration.Keywords
Funding Information
- Ministry of Higher Education, Fundamental Research Grant Scheme (FRGS/1/2020/SKK0/MUSM/02/6)
This publication has 34 references indexed in Scilit:
- Poloxamer 188 Protects Neurons against Ischemia/Reperfusion Injury through Preserving Integrity of Cell Membranes and Blood Brain BarrierPLOS ONE, 2013
- Misfolded protein aggregates: Mechanisms, structures and potential for disease transmissionSeminars in Cell & Developmental Biology, 2011
- Poloxamer 188 Protects against Ischemia-Reperfusion Injury in a Murine Hind-Limb ModelPlastic and Reconstructive Surgery, 2010
- Poloxamer 188 Copolymer Membrane Sealant Rescues Toxicity of Amyloid Oligomers In VitroJournal of Molecular Biology, 2009
- Levodopa for the Treatment of Parkinson's DiseaseNew England Journal of Medicine, 2008
- Adjunctive use of the non‐ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's diseaseEuropean Journal of Neuroscience, 2007
- Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical traumaThe FASEB Journal, 2005
- Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's diseaseBrain, 2005
- Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotectionThe FASEB Journal, 2001
- Traumatically Induced Altered Membrane Permeability: Its Relationship to Traumatically Induced Reactive Axonal ChangeJournal of Neurotrauma, 1994